Concomitant Tricuspid Valve Surgery Is Not Associated With Increased Operative Risk During Robotic Mitral Valve Surgery.
Gökhan ArslanhanMurat BaştopçuZeynep Sıla ÖzcanŞahin ŞenayMuharrem KoçyiğitAhmet Ümit GüllüAhmet AkyolCem AlhanPublished in: Innovations (Philadelphia, Pa.) (2024)
Operative mortality and early adverse outcomes did not increase with the addition of tricuspid intervention in our cohort of robotic mitral surgery patients. The robotic approach for mitral disease and coexisting tricuspid disease may offer safe results without an increased risk of postoperative PPM requirement.
Keyphrases
- mitral valve
- minimally invasive
- left atrial
- coronary artery bypass
- left ventricular
- aortic stenosis
- ejection fraction
- robot assisted
- end stage renal disease
- aortic valve
- randomized controlled trial
- newly diagnosed
- surgical site infection
- patients undergoing
- chronic kidney disease
- type diabetes
- risk factors
- coronary artery disease
- heart failure
- prognostic factors
- percutaneous coronary intervention
- patient reported outcomes
- acute coronary syndrome
- patient reported
- breast cancer risk